False-positive human immunodeficiency virus antibody test and autoimmune hemolytic anemia in a patient with angioimmunoblastic T-cell lymphoma.

A 44-year-old woman was admitted with generalized lymphadenopathy, which was diagnosed as angioimmunoblastic T-cell lymphoma (AITL). The patient showed autoimmune hemolytic anemia (AIHA), polyclonal hypergammaglobulinemia and a high antinuclear antibody titer. Moreover, a human immunodeficiency virus (HIV)-1/2 screening test using the particle agglutination method was reactive. After chemotherapy for AITL, the AIHA was eliminated, and the false-positive HIV results were no longer detected. Autoimmunity associated with AITL is the likely cause of the cross-reaction with HIV and the AIHA. It is important to recognize that the cross-reaction with HIV can be a potential complication in AITL as well as AIHA.

[1]  P. Gaulard,et al.  Advances in the understanding and management of angioimmunoblastic T‐cell lymphoma , 2010, British journal of haematology.

[2]  N. Inaba,et al.  A Human Immunodeficiency Virus Screening Algorithm to Address the High Rate of False-Positive Results in Pregnant Women in Japan , 2010, PloS one.

[3]  C. Lam,et al.  Elevated Production of B Cell Chemokine CXCL13 is Correlated with Systemic Lupus Erythematosus Disease Activity , 2009, Journal of Clinical Immunology.

[4]  H. Anton-Culver,et al.  How valid is using cancer registries’ data to identify acquired immunodeficiency syndrome-related non-Hodgkin’s lymphoma? , 2007, Cancer Causes & Control.

[5]  T. Muta,et al.  Angioimmunoblastic T-Cell Lymphoma Associated with an Antibody to Human Immunodeficiency Virus Protein , 2003, International journal of hematology.

[6]  D. M. Sander,et al.  Reactivity of Sera from Systemic Lupus Erythematosus and Sjögren’s Syndrome Patients with Peptides Derived from Human Immunodeficiency Virus p24 Capsid Antigen , 1998, Clinical Diagnostic Laboratory Immunology.

[7]  M. Poljak,et al.  Particle agglutination test "Serodia HIV-1/2" as a novel anti-HIV-1/2 screening test: comparative study on 3311 serum samples. , 1997, Folia biologica.

[8]  M. Engelhard,et al.  Angioimmunoblastic lymphadenopathy (AILD)-type T-cell lymphoma: prognostic impact of clinical observations and laboratory findings at presentation. The Kiel Lymphoma Study Group. , 1995, Annals of oncology : official journal of the European Society for Medical Oncology.

[9]  D. Isenberg,et al.  Haematological manifestations of systemic lupus erythematosus. , 1993, Blood reviews.

[10]  M. Takei,et al.  A conserved idiotype and antibodies to retroviral proteins in systemic lupus erythematosus. , 1990, The Journal of clinical investigation.

[11]  T. Fekete,et al.  Relapse and reinfection in acute pyelonephritis. , 1987, Annals of internal medicine.

[12]  S. Berk,et al.  Angioimmunoblastic lymphadenopathy, immunoblastic lymphoma, and false-positive seroconversion for human immunodeficiency virus. , 1987, Annals of internal medicine.